D-0857-2017 Class III Terminated

Recalled by Sun Pharmaceutical Industries, Inc. — Cranbury, NJ

FDA drug recall D-0857-2017 was initiated by Sun Pharmaceutical Industries, Inc. on Apr 18, 2017 and is designated Class III. Reason for recall: Failed Tablet/Capsule Specifications: out of specification results for increased tablet hardness. The recall status is terminated (terminated May 18, 2018). Affected quantity: 13,200 bottles.

Recall details

Product Type
Drugs
Report Date
May 31, 2017
Initiation Date
Apr 18, 2017
Termination Date
May 18, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
13,200 bottles

Product description

Children's Cetirizine Hydrochloride Chewable Tablets, 5 mg, 30-count bottle, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol - 389 350, Gujarat, India; Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 47335-343-83.

Reason for recall

Failed Tablet/Capsule Specifications: out of specification results for increased tablet hardness.

Distribution pattern

Nationwide in the USA and Puerto Rico

Code information

Lot #: JKR5135A, Exp 11/17

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0857-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0857-2017. Report a data issue: hello@regdatalab.com.